Alteration in the sphingolipid rheostat in which SK1 (pro-survival) is upregulated, compared to its counterpart ceramide (pro-apoptotic), in lung tissue during COVID-19 may be contributing to the overall inflammation and tissue damage seen with the SARS-CoV-2 infection. The gene discussed is SPHK1; the disease is COVID-19.